首页> 美国卫生研究院文献>Arthritis Research >Ninth Asia Pacific League Of Associations For Rheumatology (APLAR) Congress Beijing China 21-26 May 2000
【2h】

Ninth Asia Pacific League Of Associations For Rheumatology (APLAR) Congress Beijing China 21-26 May 2000

机译:第九届亚太风湿病协会联盟(APLAR)大会中国北京2000年5月21日至26日

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Congress covered the broad field of rheumatology, with participants from China, the Asia Pacific League of Associations for Rheumatology (APLAR) region and the rest of the world. The programme consisted of a mix of plenary lectures, concurrent symposia, workshops, free paper sessions and poster presentations. Basic sciences were well represented, with the general theme of inflammatory cytokines being of particular interest. One plenary lecture and a number of other presentations addressed the problem of atherosclerosis and rheumatic diseases. Diseases prominent in the region, such as Behcet's disease and Takayasu's disease, were represented with large series. Other areas of interest were musculoskeletal infections in HIV-positive patients and the management of spondyloarthritis. Although the use of the most recently developed drugs is restricted in the APLAR region because of cost factors, there were symposia on the latest pharmacological advances such as COX-2 technology, leflunomide and anti-tumour necrosis factor (TNF) therapy.
机译:大会涵盖了风湿病的广泛领域,来自中国,亚太风湿病协会联盟(APLAR)地区和世界其他地区的代表参加了会议。该方案包括全体演讲,同期专题讨论会,讲习班,免费论文会议和海报展示。很好地代表了基础科学,尤其令人关注的是炎症细胞因子的一般主题。一次全体演讲和许多其他演讲谈到了动脉粥样硬化和风湿病的问题。大区域代表了该地区突出的疾病,例如贝塞特氏病和高su氏病。其他感兴趣的领域是HIV阳性患者的肌肉骨骼感染和脊椎关节炎的治疗。尽管由于成本因素限制了在APLAR地区使用最新开发的药物,但还是有关于最新药理进展的座谈会,如COX-2技术,来氟米特和抗肿瘤坏死因子(TNF)治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号